These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18239368)

  • 1. [Development of cell-selective targeting systems of NFkappaB decoy for inflammation therapy].
    Higuchi Y; Kawakami S; Hashida M
    Yakugaku Zasshi; 2008 Feb; 128(2):209-18. PubMed ID: 18239368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of TNFalpha production in LPS induced liver failure in mice after intravenous injection of cationic liposomes/NFkappaB decoy complex.
    Higuchi Y; Kawakami S; Oka M; Yamashita F; Hashida M
    Pharmazie; 2006 Feb; 61(2):144-7. PubMed ID: 16526563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation.
    Wijagkanalan W; Kawakami S; Higuchi Y; Yamashita F; Hashida M
    J Control Release; 2011 Jan; 149(1):42-50. PubMed ID: 20035809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFkappaB decoy oligonucleotides.
    De Stefano D; De Rosa G; Carnuccio R
    Curr Opin Mol Ther; 2010 Apr; 12(2):203-13. PubMed ID: 20373264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.
    Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.
    Sawa Y; Morishita R; Suzuki K; Kagisaki K; Kaneda Y; Maeda K; Kadoba K; Matsuda H
    Circulation; 1997 Nov; 96(9 Suppl):II-280-4; discussion II-285. PubMed ID: 9386111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs.
    Kupatt C; Wichels R; Deiss M; Molnar A; Lebherz C; Raake P; von Degenfeld G; Hahnel D; Boekstegers P
    Gene Ther; 2002 Apr; 9(8):518-26. PubMed ID: 11948377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats.
    Yokoseki O; Suzuki J; Kitabayashi H; Watanabe N; Wada Y; Aoki M; Morishita R; Kaneda Y; Ogihara T; Futamatsu H; Kobayashi Y; Isobe M
    Circ Res; 2001 Nov; 89(10):899-906. PubMed ID: 11701617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
    Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
    Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular distribution of NFkappaB decoy and its inhibitory effect on TNFalpha production by LPS stimulated RAW 264.7 cells.
    Higuchi Y; Kawakami S; Nishikawa M; Yamashita F; Hashida M
    J Control Release; 2005 Oct; 107(2):373-82. PubMed ID: 16125268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
    Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jan; 28(3):532-9. PubMed ID: 16982089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFkappaB decoy delivery using dendritic poly(l-lysine) for treatment of endotoxin-induced hepatitis in mice.
    Sugao Y; Watanabe K; Higuchi Y; Kurihara R; Kawakami S; Hashida M; Katayama Y; Niidome T
    Bioorg Med Chem; 2009 Jul; 17(14):4990-5. PubMed ID: 19539484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts.
    Suzuki J; Morishita R; Amano J; Kaneda Y; Isobe M
    Gene Ther; 2000 Nov; 7(21):1847-52. PubMed ID: 11110417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of osteoclastogenesis via NFκB decoy/mannosylated cationic liposome-mediated inhibition of pro-inflammatory cytokine production from primary cultured macrophages.
    Dinh TD; Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Pharm Res; 2011 Apr; 28(4):742-51. PubMed ID: 21253857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors.
    Borgatti M; Breda L; Cortesi R; Nastruzzi C; Romanelli A; Saviano M; Bianchi N; Mischiati C; Pedone C; Gambari R
    Biochem Pharmacol; 2002 Aug; 64(4):609-16. PubMed ID: 12167479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
    Tomita N; Morishita R; Tomita S; Gibbons GH; Zhang L; Horiuchi M; Kaneda Y; Higaki J; Ogihara T; Dzau VJ
    Gene Ther; 2000 Aug; 7(15):1326-32. PubMed ID: 10918504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.